ARMING INDUCED PLURIPOTENT STEM CELLS WITH A SYNTHETIC RECEPTOR PROMOTES MASSIVE PRODUCTION OF IMMUNE EFFECTOR CELLS CREATING THE POTENTIAL FOR "OFF-THE-SHELF" IMMUNOTHERAPIES

A. Yingst, Shinya Ohara, C. Arnold, R. Koning, Ryan Larson(CTI BioPharma (United States)), Alexander Romanov(Medical University of Vienna), D. Vereide, Andrew M. Scharenberg(CTI BioPharma (Italy)), Dillon K. Jarrell, Beatriz Salinas(Universidad Carlos III de Madrid), Maureen E. Murphy(The Wistar Institute), Ryan Crisman
Cytotherapy
May 22, 2024
Cited by 0


Related Papers